US judge lets Eli Lilly continue ads for weight-loss drugs, rules against Novo Nordisk
9 Articles
9 Articles
US judge refuses to block Eli Lilly weight-loss drug ads, rules against Novo Nordisk - Regional Media News
By Jonathan Stempel Oct 26 (Reuters) - A US judge rejected on Monday Novo Nordisk's request to block Eli Lilly from continuing advertisements for weight-loss drugs that the Danish drugmaker considered false and misleading, affecting markets with tens of billions of dollars of annual sales. [...]
BT
Novo asked a New Jersey court in July for a temporary injunction against certain advertisements from Eli Lilly.
Novo Nordisk Loses Court Ruling Over Eli Lilly Obesity Drug Ads
US judge lets Eli Lilly continue ads for weight-loss drugs, rules against Novo Nordisk
Oct 26 (Reuters) - A U.S. court on Monday allowed Eli Lilly to continue weight-loss drug advertisements that rival Novo Nordisk claimed were false and misleading. (Reporting by Jonathan Stempel in New York)...
A US judge rejects Novo Nordisk's attempt to stop its competitor's advertising of the weight loss drugs Zepbound and Mounjaro
Coverage Details
Bias Distribution
- 60% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
